The monoamine oxidase inhibitory activity of essential oils obtained from Eryngium species and their chemical composition

References

• Adams M, Gmünder F, Hamburger M. 2007. Plants traditionally used in age related brain disorders – a survey of ethnobotanical literature. J Ethnopharmacol. 113:363–381.
   PubMed Web of Science ®Google Scholar
• Adams RP. 2007. Identification of essential oil components by gas chromatograph/quadrupole mass spectrometry. Carol Stream: Allured Publishing.
   Google Scholar
• Binda C, Hubálek F, Li M, Edmondson DE, Mattevi A. 2004. Crystal structure of human monoamine oxidase B, a drug target enzyme monotopically inserted into the mitochondrial outer membrane. FEBS Lett. 564:225–228.
   PubMed Web of Science ®Google Scholar
• Calviño CI, Martínez SG, Downie SR. 2008. The evolutionary history of Eryngium (Apiaceae, Saniculoideae): rapid radiations, long distance dispersals, and hybridizations. Mol Phylogenet Evol. 46:1129–1150.
   PubMed Web of Science ®Google Scholar
• Cavaleiro C, Gonçalves MJ, Serra D, Santoro G, Tomi F, Bighelli A, Salgueiro L, Casanova J. 2011. Composition of a volatile extract of Eryngium duriaei subsp. juresianum (M. Laínz) M. Laínz, signalised by the antifungal activity. J Pharm Biomed Anal. 54:619–622.
   PubMed Web of Science ®Google Scholar
• Copeland R. 2005. Evaluation on enzyme inhibitors in drug discovery: a guide for medicinal chemists and pharmacologists. New York: Wiley.
   Google Scholar
• Finberg JPM, Gillman K. 2011. Selective inhibitors of monoamine oxidase type B and the “cheese effect”. Int Rev Neurobiol. 100:169–190.
   PubMed Web of Science ®Google Scholar
• Flamini G, Tebano M, Cioni PL. 2008. Composition of the essential oils from leafy parts of the shoots, flowers and fruits of Eryngium amethystinum from Amiata Mount (Tuscany, Italy). Food Chem. 107:671–674.
   Web of Science ®Google Scholar
• Helguera MA, Perez-Machado G, Cordeiro NDSM, Borges F. 2012. Discovery of MAO-B inhibitors – present status and future directions. Part I: oxygen heterocycles and analogs. Mini Rev Med Chem. 12:907–919.
   PubMed Web of Science ®Google Scholar
• Jenner P. 2012. Mitochondria, monoamine oxidase B and Parkinson’s disease. Basal Ganglia 2:S3–S7.
   Google Scholar
• Khader M, Bresgen N, Eckl PM. 2010. Antimutagenic effects of ethanolic extracts from selected Palestinian medicinal plants. J Ethnopharmacol. 127:319–324.
   PubMed Web of Science ®Google Scholar
• Küpeli E, Kartal M, Aslan S, Yesilada E. 2006. Comparative evaluation of the anti-inflammatory and antinociceptive activity of Turkish Eryngium species. J Ethnopharmacol. 107:32–37.
   PubMed Web of Science ®Google Scholar
• Limberger RP, Sobral M, Henriques AT, Menut C, Bessière J-M. 2004. Óleos voláteis de espécies de Myrcia nativas do Rio Grande do Sul. Quim Nova. 27:916–919.
   Web of Science ®Google Scholar
• Löhle M, Reichmann H. 2011. Controversies in neurology: why monoamine oxidase B inhibitors could be a good choice for the initial treatment of Parkinson's disease? BMC Neurol. 11:112–118.
   PubMed Web of Science ®Google Scholar
• Mathias ME, Constance L, Araujo D. 1972. Umbelliferae. In: Reitz R, editor. Flora ilustrada catarinense. Itajaí: Herbário Barbosa Rodrigues. p. 100–197.
   Google Scholar
• McIntosh TJ, Simon SA, MacDonald RC. 1980. The organization of n-alkanes in lipid bilayers. Biochim Biophys Acta. 597:445–463.
   PubMed Web of Science ®Google Scholar
• Novaroli L, Reist M, Favre E, Carotti A, Catto M, Carrupt P-A. 2005. Human recombinant monoamine oxidase B as reliable and efficient enzyme source for inhibitor screening. Bioorg Med Chem. 13: 6212–6217.
   PubMed Web of Science ®Google Scholar
• Palá-Paúl J, Brophy JJ, Pérez-Alonso MJ, Usano J, Soria SC. 2007. Essential oil composition of the different parts of Eryngium corniculatum Lam. (Apiaceae) from Spain. J Chromatogr A. 1175:289–293.
   PubMed Web of Science ®Google Scholar
• Palá-Paúl J, Copeland LM, Brophy JJ, Goldsack RJ. 2006. Essential oil composition of E. rosulatum P.W. Michael ined.: a new undescribed species from eastern Australia. Biochem Syst Ecol. 34:796–801.
   Web of Science ®Google Scholar
• Palá-Paúl J, Pérez-Alonso MJ, Velasco-Negueruela A, Vadaré J, Villa AM, Sanz J, Brophy JJ. 2005a. Essential oil composition of the different parts of Eryngium bourgatii Gouan from Spain. J Chromatogr A. 1074:235–239.
   PubMed Web of Science ®Google Scholar
• Palá-Paúl J, Pérez-Alonso MJ, Velasco-Negueruela A, Vadaré J, Villa AM, Sanz J, Brophy JJ. 2005b. Analysis of the essential oil composition from the different parts of Eryngium glaciale Boiss. from Spain. J Chromatogr A. 1094:179–182.
   PubMed Web of Science ®Google Scholar
• Passos CS, Soldi TC, Abib RT, Apel MA, Simões-Pires C, Marcourt L, Gottfried C, Henriques AT. 2013. Monoamine oxidase inhibition by monoterpene indole alkaloids and fractions obtained from Psychotria suterella and Psychotria laciniata. J Enzyme Inhib Med Chem. 28:611–618.
   PubMed Web of Science ®Google Scholar
• Pope JM, Dubro DW. 1986. The interaction of n-alkanes and n-alcohol with lipid bilayer membranes: a 2H-NMR study. Biochim Biophys Acta. 858:243–253.
   Web of Science ®Google Scholar
• Simões-Pires CA, Debenedetti S, Spegazzini E, Mentz LA, Matzenbacher NI, Limberger RP, Henriques AT. 2005. Investigation of the essential oil from eight species of Baccharis belonging to sect. Caulopterae (Asteraceae, Astereae): a taxonomic approach. Plant Syst Evol. 253:23–32.
   Web of Science ®Google Scholar
• Szögyi M, Cserháti T. 1993. Interaction of monoamine oxidase inhibitory drugs with some phospholipids. J Pharm Biomed Anal. 11:563–568.
   PubMed Web of Science ®Google Scholar
• Tao G, Irie Y, Li D, Keung WM. 2005. Eugenol and its structural analogs inhibit monoamine oxidase A and exhibit antidepressant-like activity. Bioorg Med Chem. 13:4777–4788.
   PubMed Web of Science ®Google Scholar
• Thiem B, Kikowska M, Kurowska A, Kalemba D. 2011. Essential oil composition of the different parts and in vitro shoot culture of Eryngium planum L. Molecules 16:7115–7124.
   PubMed Web of Science ®Google Scholar
• Williamson EM. 2001. Synergy and other interactions in phytomedicines. Phytomedicine 8:401–409.
   PubMed Web of Science ®Google Scholar
• Youdim MBH, Bakhle YS. 2006. Monoamine oxidase: isoforms and inhibitors in Parkinson’s disease and depressive illness. Br J Pharmacol. 147:S287–S296.
   PubMed Web of Science ®Google Scholar
• Youdim MBH, Edmondson D, Tipton KF. 2006. The therapeutic potential of monoamine oxidase inhibitors. Nat Rev Neurosci. 7:295–309.
   PubMed Web of Science ®Google Scholar